Inventor · disambiguated record
Kanji Meghpara
Also filed as: MEGHPARA KANJI
15 granted patents·12 pending applications·57 citations·filing 2005–2024
91Inventor score
Files withAMNEAL COMPLEX PRODUCTS RES LLC9KASHIV BIOSCIENCES LLC8KASHIV PHARMA LLC4KASHIV SPECIALTY PHARMACEUTICALS LLC3GLAXOSMITHKLINE LLC1
Top patents by PatentIndex Score
27 records- 0197US10898430B2Self-regulating osmotic gastroretentive drug delivery systemsKASHIV BIOSCIENCES LLC·Filed 2020·Granted Jan 26, 2021·5 cites·12 claims
- 0297US10849846B2Self-regulating osmotic gastroretentive drug delivery systemsKASHIV BIOSCIENCES LLC·Filed 2020·Granted Dec 1, 2020·6 cites·20 claims
- 0396US11179320B2Self-regulating osmotic gastroretentive drug delivery systemsKASHIV SPECIALTY PHARMACEUTICALS LLC·Filed 2021·Granted Nov 23, 2021·3 cites·24 claims
- 0495US10744083B2Self-regulating osmotic gastroretentive drug delivery systemsKASHIV BIOSCIENCES LLC·Filed 2019·Granted Aug 18, 2020·6 cites·13 claims
- 0595US7943167B2Compositions with hydrophilic drugs in a hydrophobic mediumMCNEIL PPC INC·Filed 2006·Granted May 17, 2011·27 cites·10 claims
- 0694US10952957B2Self-regulating osmotic gastroretentive drug delivery systemsKASHIV SPECIALTY PHARMACEUTICALS LLC·Filed 2020·Granted Mar 23, 2021·2 cites·16 claims
- 0792US11793747B2Self-regulating osmotic gastroretentive drug delivery systemsAMNEAL COMPLEX PRODUCTS RES LLC·Filed 2021·Granted Oct 24, 2023·1 cites·12 claims
- 0889US11318091B2Gastroretentive dosage forms for sustained drug deliveryAMNEAL COMPLEX PRODUCTS RES LLC·Filed 2021·Granted May 3, 2022·1 cites·20 claims
- 0987US11964048B2Sustained release compositions comprising liothyronineAMNEAL COMPLEX PRODUCTS RES LLC·Filed 2021·Granted Apr 23, 2024·1 cites·25 claims
- 1087US11007145B2Gastroretentive dosage forms for sustained drug deliveryKASHIV SPECIALTY PHARMACEUTICALS LLC·Filed 2020·Granted May 18, 2021·1 cites·14 claims
- 1187US2024000701A1Self-regulating osmotic gastroretentive drug delivery systemsAMNEAL COMPLEX PRODUCTS RES LLC·Filed 2023·Application pending·0 cites
- 1286US10918597B2Gastroretentive dosage forms for sustained drug deliveryKASHIV PHARMA LLC·Filed 2018·Granted Feb 16, 2021·1 cites·27 claims
- 1386US2024335376A1Gastroretentive dosage forms for sustained drug deliveryAMNEAL COMPLEX PRODUCTS RES LLC·Filed 2024·Application pending·0 cites
- 1485US12042559B2Gastroretentive dosage forms for sustained drug deliveryAMNEAL COMPLEX PRODUCTS RES LLC·Filed 2023·Granted Jul 23, 2024·0 cites·20 claims
- 1585US10857098B2Gastroretentive dosage forms for sustained drug deliveryKASHIV BIOSCIENCES LLC·Filed 2020·Granted Dec 8, 2020·1 cites·14 claims
- 1685US10406234B2Method of manufacturing fine particles suitable for orally disintegrating pharmaceutical dosage formsKASHIV BIOSCIENCES LLC·Filed 2015·Granted Sep 10, 2019·2 cites·17 claims
- 1780US2022218604A1Gastroretentive dosage forms for sustained drug deliveryAMNEAL COMPLEX PRODUCTS RES LLC·Filed 2022·Application pending·0 cites
- 1865US2023330006A1Sustained Release Compositions Comprising LiothyronineAMNEAL COMPLEX PRODUCTS RES LLC·Filed 2023·Application pending·0 cites
- 1964US2019343957A1Method Of Manufacturing Fine Particles Suitable For Orally Disintegrating Pharmaceutical Dosage FormsKASHIV BIOSCIENCES LLC·Filed 2019·Application pending·0 cites
- 2058US2022079896A1Delayed release compositionsAMNEAL COMPLEX PRODUCTS RES LLC·Filed 2021·Application pending·0 cites
- 2152US2022241184A1Gastroretentive dosage forms of levodopa and carbidopaKASHIV BIOSCIENCES LLC·Filed 2020·Application pending·0 cites
- 2251US2007134493A1Compositions and capsules with stable hydrophilic layersMEGHPARA KANJI·Filed 2005·Application pending·0 cites
- 2348US2018296486A1Food independent immediate release drug formulation with abuse deterrence and overdose protectionKASHIV PHARMA LLC·Filed 2018·Application pending·0 cites
- 2445US2019282508A1Extended release drug formulation with overdose protection and abuse deterrenceKASHIV PHARMA LLC·Filed 2017·Application pending·0 cites
- 2544US2019054031A1Overdose protection and abuse deterrent immediate release drug formulationKASHIV PHARMA LLC·Filed 2016·Application pending·0 cites
- 2641US10632113B2Abuse-resistant drug formulations with built-in overdose protectionKASHIV BIOSCIENCES LLC·Filed 2015·Granted Apr 28, 2020·0 cites·24 claims
- 2731US2014065213A1Sustained Release Paracetamol FormulationsGLAXOSMITHKLINE LLC·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →